Latest
-
Congress Should Responsibly Lift the Debt Limit
Read moreThe suspension of the debt ceiling expired on July 31, at which point the ceiling was automatically raised to the current level of debt – around $28.5...
-
Appropriations Watch: FY 2021
Read moreUpdated 7/30/2021: The House passed an emergency supplemental appropriations measure of $1.9 billion, intended to to address security concerns at the...
-
Fiscal State of the Nation Introduced in the Senate and House
Read moreSenators Kyrsten Sinema (D-AZ), Joni Ernst (R-IA), Angus King (I-ME), Mark Kelly (D-AZ), Mike Braun (R-IN), Steve Daines (R-MT), and Jacky Rosen (D-NV...
-
Policymakers Shouldn't Attach More Borrowing to a Debt Ceiling Increase
Read moreThe debt ceiling, or the statutory limit on the total amount of debt the federal government can accrue, is set to come back on August 1 after being...
-
What's in the Bipartisan Infrastructure Investment and Jobs Act?
Read moreUPDATE 8/5: We have published a new summary of the bipartisan Infrastructure Investment and Jobs Act based on a recently published score from the...
-
Bipartisan Infrastructure Act a Good Start, But Needs More Pay-Fors
Read moreToday, negotiators announced a final legislative package on their $550 billion Bipartisan Infrastructure Deal and presented details of that agreement...
-
Q&A: Everything You Should Know About the Debt Ceiling
Read moreThis paper has been updated here. The federal debt ceiling will be reinstated on August 1, 2021, at around $28.5 trillion. At that point, the Treasury...
-
Trust Fund Solutions Would Be Pro-Growth
Read moreIn our recent paper “ The Case for Trust Fund Solutions,” we showed that making the Social Security, Medicare, and highway trust funds solvent would...
-
Injecting Price Competition into Medicare Part B Drugs
Read moreMedicare Part B, which covers outpatient physician services, pays for physician-administered drugs by reimbursing physicians the average cost for each...
-
Limiting Evergreening for Name-Brand Prescription Drugs
Read moreTo encourage medical innovation, the Food and Drug Administration (FDA) grants temporary market exclusivities to new brand name drugs. These...
-
Two Ways to Reduce Prescription Drug Costs
Read moreHigh and rising prescription drug costs are contributing to the budgetary pressure faced by the federal government. Also, a significant number of...
-
Can Medicare Advantage Reforms Save the Trust Fund?
Read moreWe estimate costs will exceed dedicated revenue by about $505 billion over the next decade, leaving a $360 billion solvency gap after accounting for...